<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20160618028524N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-11-26</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>The impact of family empowerment model on life quality of children with epilepsy in selected centers of Shiraz and Kerman universities of medical sciences, 2018</public_title>
      <acronym></acronym>
      <scientific_title>The impact of family empowerment model on life quality of children with epilepsy in selected centers of Shiraz and Kerman universities of medical sciences, 2018</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-11-26</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>80</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/34580</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: Sampling will be done via permuted block randomization. In doing so, a digit will be randomly selected among random numbers and then, 40 blocks with block size of two will be chosen successively as follows: AB (4-0) and BA (9-5). After that, groups A and B will be allocated to intervention and control groups, respectively.</study_design>
      <phase>N/A</phase>
      <hc_freetext>The family empowerment.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The intervention group includes the parents who have children with epilepsy, meet the inclusion criteria, and are willing to participate in the research. In the first session, the parents will be required to complete the QOLCE questionnaire. The family empowerment intervention is carried out through two educational sessions. In the first session, the parents will be trained regarding the process, clinical symptoms, diagnosis, and probable complications of the disease through question and answer and educational pamphlets. The second session will involve face-to-face training during seizure, available treatments, recovery process after treatment, and necessity for long-term follow-ups. The training will be carried out both individually and in groups using educational pamphlets. After a month, the questionnaire will be completed by the parents again. Intervention 2: Control group: After selecting the control group participants, they will be required to complete the QOLCE questionnaire in the first session. Considering ethics, the control group parents will receive the educational pamphlets after completing the questionnaire. After a month, the questionnaire will be completed by the parents again.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
A large proportion of the data, including the information related to the main outcome measure, will be shared after the end of the study.

When:
After the end of the study

To whom:
Researchers in academic and scientific institutions

Conditions:
Researchers in academic and scientific institutions can use the present study results for their scientific and research works after gaining permission from the authors.

Where to obtain:
meshham5@gmail.com
zahra.mahdavi@iauk.ac.ir

How to obtain:
Researchers in academic and scientific institutions can use the present study results for their scientific and research works after gaining permission from the authors.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zahra Mahdavi Khanouki</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Valiasr Blvd., Islamic Azad University, Kerman Branch</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7635131167</zip>
        <telephone>+98 343321004350</telephone>
        <email>zahra.mahdavi@iauk.ac.ir</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr.Hamid Nemati</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Pediatric Neurology Ward,  Namazi Hospital,  Namazi Square,  Shiraz</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7187649635</zip>
        <telephone>+98 71 3647 4298</telephone>
        <email>Nematih@sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Parents of children aged 3-7 years with epilepsy who have 6 months of diagnosis and initiation of treatment, and according to the doctor's records and diagnosis, need to go and follow up for at least one year.
Acquiring informed consent and willingness to participate in research by parents
Having Diploma education to bachelor's degree and enough monthly income
Not participating in the same educational program
The absence of physical and psychological disruption of daily activities
Parents are not personnel and health care providers</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Parents of children hospitalized with febrile  of convulsion</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Lifestyle</i_code>
      <i_code>Lifestyle</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The intervention group includes the parents who have children with epilepsy, meet the inclusion criteria, and are willing to participate in the research. In the first session, the parents will be required to complete the QOLCE questionnaire. The family empowerment intervention is carried out through two educational sessions. In the first session, the parents will be trained regarding the process, clinical symptoms, diagnosis, and probable complications of the disease through question and answer and educational pamphlets. The second session will involve face-to-face training during seizure, available treatments, recovery process after treatment, and necessity for long-term follow-ups. The training will be carried out both individually and in groups using educational pamphlets. After a month, the questionnaire will be completed by the parents again.</i_keyword>
      <i_keyword>Control group: After selecting the control group participants, they will be required to complete the QOLCE questionnaire in the first session. Considering ethics, the control group parents will receive the educational pamphlets after completing the questionnaire. After a month, the questionnaire will be completed by the parents again.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The main outcome measures of this study are executing the family empowerment program and enhancing the life quality of children suffering from epilepsy. The data will be collected using the Quality of Life in Children with Epilepsy (QOLCE) questionnaire, which is a specific instrument for assessing such children’s quality of life. This instrument has been derived from Health-Related Quality of Life (HRQoL) questionnaire, which is used to evaluate healthcare and medical interventions in both clinical and social domains. Timepoint: The QOLCE questionnaire will be completed by the two groups in the first session. The intervention group will receive the family empowerment program over two educational sessions. In the first session, the parents will be trained regarding the process, clinical symptoms, diagnosis, and probable complications of the disease through question and answer and educational pamphlets. The second session will involve face-to-face training during seizure, available treatments, recovery process after treatment, and necessity for long-term follow-ups. The training will be carried out both individually and in groups using educational pamphlets. After a month, the questionnaire will be completed by the parents again. Considering ethics, the control group parents will receive the educational pamphlets after completing the questionnaire. Method of measurement: The data will be collected using the QOLCE questionnaire, which is a specific instrument for assessing quality of life in children suffering from epilepsy. This instrument has been derived from HRQoL questionnaire, which is used to evaluate healthcare and medical interventions in both clinical and social domains.Children with seizure disorders are normally faced with an increased risk of behavioral and emotional problems, familial and social decline, and lower quality of life. QOLCE evaluates such children’s quality of life in four dimensions, namely cognitive function (22 items), emotional function (17 items), social function (7 items), and physical function (9 items). The items are responded via a 5-point Likert scale. Accordingly, scores 0, 25, 50, 75, and 100 represent very low, low, average, high, and very high functions, respectively. The reliability of QOLCE was approved by Goodwin et al. in 2015.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-10-02</approval_date>
        <contact_name>Ethic's committee of Shiraz University of Medical Sciences</contact_name>
        <contact_address>Central Building of Shiraz University of Medical Sciences, opposite Felestine St. Zand St. Shiraz, Fars Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
